DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Kayexalate (Sodium Polystyrene Sulfonate) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Kayexalate (Sodium Polystyrene Sulfonate) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (58)
Death (2)
Life Threatening Events (13)
Disability (1)

Reports by Reaction Type

Thrombocytopenia (12)Anaemia (12)Renal Impairment (12)Tubulointerstitial Nephritis (8)Dizziness (8)Nephropathy (8)Hypokalaemia (6)Condition Aggravated (6)Hydrocephalus (5)Cardiomyopathy (5)Lung Disorder (5)Sepsis (5)

Below are a few examples of reports where side effects / adverse reactions may be related to Kayexalate (Sodium Polystyrene Sulfonate). For a complete list or a specific selection of reports, please use the links above.

Possible Kayexalate side effects in 82 year old female

Reported by a physician from France on 2012-08-21

Patient: 82 year old female

Reactions: Death, Hyperkalaemia, Hypokalaemia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ixabepilone
    Start date: 2010-06-02
    End date: 2011-12-14

Kayexalate



Possible Kayexalate side effects in 82 year old female

Reported by a physician from France on 2012-08-07

Patient: 82 year old female

Reactions: Hyperkalaemia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kayexalate

Ixabepilone
    Start date: 2010-06-02
    End date: 2011-12-14



Possible Kayexalate side effects in

Reported by a individual with unspecified qualification from United States on 2012-07-17

Patient:

Reactions: Circumstance or Information Capable of Leading To Medication Error

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kayexalate



Possible Kayexalate side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-08

Patient: 56 year old male, weighing 92.0 kg (202.4 pounds)

Reactions: Condition Aggravated, Cardiomyopathy, Bladder Cancer, Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Fenofibrate
    Administration route: Oral
    Indication: Hypertriglyceridaemia

Januvia
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-10-01

Aspirin
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Diamicron
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus

Bisoprolol Fumarate
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Kayexalate
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01

Minirin
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Perindopril Erbumine
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Actos
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-03-01
    End date: 2010-02-01

Prazosin HCL
    Indication: Hypertension
    End date: 2010-02-01

Allopurinol
    Administration route: Oral
    Indication: Hyperuricaemia



Possible Kayexalate side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-29

Patient: 56 year old male, weighing 92.0 kg (202.4 pounds)

Reactions: Bladder Cancer

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Diamicron
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus

Bisoprolol Fumarate
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Aspirin
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Prazosin HCL
    Indication: Hypertension
    End date: 2010-02-01

Actos
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-03-01
    End date: 2010-02-01

Minirin
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Fenofibrate
    Administration route: Oral
    Indication: Hypertriglyceridaemia

Kayexalate
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01

Januvia
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-10-01

Allopurinol
    Administration route: Oral
    Indication: Hyperuricaemia

Perindopril Erbumine
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01



Possible Kayexalate side effects in male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-05-25

Patient: male

Reactions: Anaemia, Condition Aggravated, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone TAB
    Dosage: 1 df
    Administration route: Oral
    Start date: 2011-05-01

Renagel
    Dosage: 1 df
    Administration route: Oral

Aranesp
    Dosage: 0.0667 df

Calciparine
    Start date: 2011-07-08
    End date: 2011-08-08

Citalopram Hydrobromide
    Administration route: Oral

Depakene
    Dosage: 2 df
    Administration route: Oral
    Start date: 2011-07-16

Eupressyl
    Dosage: 3 df
    Administration route: Oral
    Start date: 2011-05-29

Kayexalate
    Dosage: 0.4286 df
    Start date: 2011-06-03

Calcium Carbonate
    Administration route: Oral

Other drugs received by patient: Levetiracetam



Possible Kayexalate side effects in 80 year old male

Reported by a physician from United States on 2012-05-15

Patient: 80 year old male

Reactions: Rectal Haemorrhage, Gastrointestinal Mucosal Necrosis, Ulcer, Faeces Discoloured, Haemoglobin Decreased, Haematocrit Decreased, Bacteraemia, Injury, Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kayexalate

Other drugs received by patient: Insulin; Dextrose 5%; Sorbitol 50pc INJ



Possible Kayexalate side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-19

Patient: 56 year old male

Reactions: Bladder Transitional Cell Carcinoma Stage II, Cardiomyopathy

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Diamicron (Gliclazide)
    Dosage: 30 mg, qd, oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus

Perindopril Erbumine
    Dosage: 2.5 mg
    Start date: 2009-12-01

Aceon
    Dosage: 2.5 mg,qd,oral
    Administration route: Oral

Bisoprolol Fumarate
    Dosage: 2.5 mg, qd, oral
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Allopurinol
    Dosage: 300 mg, qd, oral
    Administration route: Oral
    Indication: Hyperuricaemia

Fenofibrate
    Dosage: 200 mg, qd, oral
    Administration route: Oral
    Indication: Hypertriglyceridaemia

Januvia
    Dosage: 100 mg, qd, oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-10-01

Kayexalate
    Dosage: 1 unit every 2 weeks, oral
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01

Aspirin
    Dosage: 75 mg, qd, oral
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Actos
    Dosage: 30 mg, qd, oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-03-01
    End date: 2010-02-01

Minirin
    Dosage: 100 ug, tid, oral
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Prazosin HCL
    Dosage: 5 mg, qd, oral
    Administration route: Oral
    Indication: Hypertension
    End date: 2010-02-01



Possible Kayexalate side effects in 56 year old male

Reported by a individual with unspecified qualification from France on 2012-03-13

Patient: 56 year old male

Reactions: Condition Aggravated, Cardiomyopathy, Bladder Transitional Cell Carcinoma Stage II, Infectious Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Fenofibrate
    Dosage: 200 mg, before 2006, oral
    Administration route: Oral
    Indication: Hypertriglyceridaemia
    Start date: 2006-01-01

Diamicron (Gliclazide) Tablet 30 MG
    Dosage: 30 mg, before 2006, oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-01-01

Allopurinol
    Dosage: 300 mg, before 2006, oral
    Administration route: Oral
    Indication: Hyperuricaemia
    Start date: 2006-01-01

Januvia
    Dosage: 100 mg, oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-10-01

Actos
    Dosage: 30 mg, oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-03-01
    End date: 2010-02-01

Perindopril Erbumine
    Dosage: 2.5 mg, oral
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Aspirin
    Dosage: 75 mg, oral
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Bisoprolol Fumarate
    Dosage: 2.5 mg, oral
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Desmopressin Acetate
    Dosage: 300 ug, oral
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Prazosin HCL
    Dosage: oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-01-01
    End date: 2010-02-01

Kayexalate
    Dosage: oral
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01



Possible Kayexalate side effects in 34 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-12

Patient: 34 year old female

Reactions: Dialysis, Maternal Exposure During Pregnancy, Cervix Disorder, Foetal Death, Uterine Contractions During Pregnancy, Abortion Spontaneous

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 100 mg, bid : 50 mg, bid : 25 mg, bid
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-11-05
    End date: 2008-12-17

Neoral
    Dosage: 100 mg, bid : 50 mg, bid : 25 mg, bid
    Indication: Product Used FOR Unknown Indication
    End date: 2008-10-21

Neoral
    Dosage: 100 mg, bid : 50 mg, bid : 25 mg, bid
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-10-22
    End date: 2008-11-05

Rhinofluimucil (Acetycysteine, Benzalkonium Chloride, Tuaminoheptane)
    Dosage: 2 bid
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-11-07
    End date: 2008-11-10

Atarax
    Dosage: 25 mg, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-08-18
    End date: 2008-12-17

Amlodipine Besylate
    Dosage: 5 mg, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-06-20
    End date: 2008-09-16

Amlodipine Besylate
    Dosage: 5 mg, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-09-17
    End date: 2008-12-15

Venofer
    Dosage: 1, 2x/w : 1, 3x/w : 1, 1x/w
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-06-13
    End date: 2008-10-16

Venofer
    Dosage: 1, 2x/w : 1, 3x/w : 1, 1x/w
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-12-15
    End date: 2008-12-17

Azathioprine
    Dosage: 75 mg, bid : 50 mg, bid : 25 mg
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-06-13
    End date: 2008-08-21

Azathioprine
    Dosage: 75 mg, bid : 50 mg, bid : 25 mg
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-08-22
    End date: 2008-09-05

Azathioprine
    Dosage: 75 mg, bid : 50 mg, bid : 25 mg
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-09-06
    End date: 2008-09-16

Rubozinc (Zinc Gluconate)
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-08-29
    End date: 2008-09-16

Nexium
    Dosage: 40 mg, qd : 20 mg
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-08-22
    End date: 2008-12-17

Nexium
    Dosage: 40 mg, qd : 20 mg
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-06-13
    End date: 2008-08-21

Kayexalate
    Dosage: 1 , qd : 2 , qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-06-13
    End date: 2008-08-04

Kayexalate
    Dosage: 1 , qd : 2 , qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-08-05
    End date: 2008-11-15

Mucomyst
    Dosage: 200 mg, bid
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-11-07
    End date: 2008-11-10

UN-Alfa (Alfacalcidol)
    Dosage: 5 mcg, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-07-04
    End date: 2008-10-17

Renagel
    Dosage: 800 mg, tid
    Indication: Hyperphosphataemia
    Start date: 2008-08-28
    End date: 2008-12-15

Cefpodoxime Proxetil
    Dosage: 100 mg, bid
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-11-07
    End date: 2008-11-17

Aranesp
    Dosage: 60 mcg, 1x/w : 80 mcg, 2x/w
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-09-29
    End date: 2008-12-17

Aranesp
    Dosage: 60 mcg, 1x/w : 80 mcg, 2x/w
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-07-27
    End date: 2008-09-28

Tixocortol Pivalate
    Dosage: 2 bid
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-10-31
    End date: 2008-11-07

Antibiotrex (Erythromycin, Isotretinoin)
    Dosage: 1 day, bid
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-08-29
    End date: 2008-09-16

Furosemide
    Dosage: 500 mg, bid
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-06-13
    End date: 2008-12-15

Folic Acid
    Dosage: 5 mg, bid
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-10-08
    End date: 2008-12-17



Possible Kayexalate side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-09

Patient: male

Reactions: Type 2 Diabetes Mellitus, Bladder Cancer Stage II, Cardiac Failure, Congestive Cardiomyopathy, Cardiomyopathy, Appendicitis, Hyperuricaemia, Infectious Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Actos
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-03-01
    End date: 2010-02-01

Allopurinol
    Administration route: Oral
    Indication: Hyperuricaemia

Aspirin
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Januvia
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-10-01

Kayexalate
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01

Prazosin HCL
    Administration route: Oral
    Indication: Hypertension
    End date: 2010-02-01

Diamicron
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2010-03-30

Prazosin HCL
    Indication: Congestive Cardiomyopathy

Minirin
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Perindopril Erbumine
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Kayexalate
    Indication: Congestive Cardiomyopathy

Bisoprolol Fumarate
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Fenofibrate
    Administration route: Oral
    Indication: Hypertriglyceridaemia

Other drugs received by patient: Metformin HCL; Victoza



Possible Kayexalate side effects in 34 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-08

Patient: 34 year old female

Reactions: Maternal Exposure During Pregnancy, Foetal Death

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Amlodipine Besylate
    Dosage: 10 mg, 1x/day
    Start date: 2008-09-17
    End date: 2008-12-15

Atarax
    Dosage: 25 mg, 1x/day
    Start date: 2008-08-18
    End date: 2008-12-17

Tixocortol Pivalate
    Dosage: 2 gtt, 2x/day
    Start date: 2008-10-31
    End date: 2008-11-07

Kayexalate
    Dosage: unk
    Start date: 2008-06-13
    End date: 2008-08-04

Acetylcysteine
    Dosage: unk
    Start date: 2008-11-07
    End date: 2008-11-10

Nexium
    Dosage: 40 mg, 1x/day
    Start date: 2008-06-13
    End date: 2008-08-21

Amlodipine Besylate
    Dosage: 5 mg, 1x/day
    Start date: 2008-06-20
    End date: 2008-09-16

Isotretinoin
    Dosage: unk
    Start date: 2008-08-29
    End date: 2008-09-16

Lasix
    Dosage: 500 mg, 2x/day
    Start date: 2008-06-13
    End date: 2008-12-15

Folic Acid
    Dosage: 5 mg, 2x/day
    Start date: 2008-10-08
    End date: 2008-12-17

Mucomyst
    Dosage: 200 mg, 2x/day
    Start date: 2008-11-07
    End date: 2008-11-10

Aranesp
    Dosage: 60 ug, weekly
    Start date: 2008-08-27
    End date: 2008-09-28

Imuran
    Dosage: 1.5 df, 2x/day
    Start date: 2008-06-13
    End date: 2008-08-21

Kayexalate
    Dosage: unk
    Start date: 2008-08-05
    End date: 2008-11-15

Cefpodoxime Proxetil
    Dosage: 100 mg, 2x/day
    Start date: 2008-11-07
    End date: 2008-11-17

Imuran
    Dosage: 0.5 df, 1x/day
    Start date: 2008-09-06
    End date: 2008-09-16

Neoral
    Dosage: 100 mg, 2x/day
    End date: 2008-10-21

Neoral
    Dosage: 25 mg, 2x/day
    Start date: 2008-11-06
    End date: 2008-12-17

Renagel
    Dosage: 800 mg, 3x/day
    Start date: 2008-08-28
    End date: 2008-12-15

UN-Alfa
    Dosage: 0.5 ug, 1x/day
    Start date: 2008-07-04
    End date: 2008-10-17

Venofer
    Dosage: 100 ug, tree time x week
    Start date: 2008-10-17
    End date: 2008-12-14

Imuran
    Dosage: 1 df, 2x/day
    Start date: 2008-08-22
    End date: 2008-09-05

Neoral
    Dosage: 50 mg, 2x/day
    Start date: 2008-10-22
    End date: 2008-11-05

Erythromycin
    Dosage: unk
    Start date: 2008-08-29
    End date: 2008-09-16

Aranesp
    Dosage: 80 ug, unk
    Start date: 2008-09-29
    End date: 2008-12-17

Venofer
    Dosage: 100 ug, twice x week
    Start date: 2008-06-13
    End date: 2008-10-16

Rubozinc
    Dosage: 15 mg, 1x/day
    Start date: 2008-08-29
    End date: 2008-09-16

Nexium
    Dosage: 20 mg, 1x/day
    Start date: 2008-08-22
    End date: 2008-12-17

Venofer
    Dosage: 100 ug, twice x week
    Start date: 2008-12-15
    End date: 2008-12-17



Possible Kayexalate side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-07

Patient: 56 year old male

Reactions: Bladder Transitional Cell Carcinoma Stage II

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Actos
    Administration route: Oral
    Start date: 2006-03-01
    End date: 2010-02-01

Diamicron
    Administration route: Oral

Metformin HCL

Kayexalate
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01

Januvia
    Administration route: Oral
    Start date: 2009-10-01

Allopurinol
    Administration route: Oral
    Indication: Hyperuricaemia

Perindopril Erbumine
    Administration route: Oral
    Start date: 2009-12-01

Minirin
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Bisoprolol Fumarate
    Administration route: Oral
    Start date: 2009-12-01

Aspirin
    Administration route: Oral
    Start date: 2009-12-01

Prazosin HCL
    Administration route: Oral
    End date: 2010-02-01

Fenofibrate
    Administration route: Oral
    Indication: Hypertriglyceridaemia



Possible Kayexalate side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-02

Patient: 56 year old male

Reactions: Bladder Transitional Cell Carcinoma Stage II

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prazosin HCL
    Dosage: 5 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    End date: 2010-02-01

Bisoprolol Fumarate
    Dosage: 2.5 mg, 1x/day
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Januvia
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-10-01

Diamicron
    Dosage: 30 mg, 1x/day
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus

Perindopril Erbumine
    Dosage: 2.5 mg, 1x/day
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Aspirin
    Dosage: 75 mg, 1x/day
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Kayexalate
    Dosage: 1 df, 2x/week
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01

Minirin
    Dosage: 100 ug, 3x/day
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Actos
    Dosage: 30 mg, 1x/day
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-03-01
    End date: 2010-02-01

Fenofibrate
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Hypertriglyceridaemia

Allopurinol
    Dosage: 300 mg, 1x/day
    Administration route: Oral
    Indication: Hyperuricaemia



Possible Kayexalate side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-02

Patient: male

Reactions: Bladder Cancer Stage II, Cardiac Failure, Cardiomyopathy, Appendicitis, Infectious Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Diamicron
    Administration route: Oral
    Indication: Pain
    End date: 2010-03-30

Minirin
    Administration route: Oral
    Indication: Diabetes Insipidus
    Start date: 1995-01-01

Actos
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2006-03-01
    End date: 2010-02-01

Allopurinol
    Administration route: Oral
    Indication: Hyperuricaemia

Perindopril Erbumine
    Dosage: 100 mcg thrice
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 1999-12-01

Januvia
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-10-01

Prazosin HCL
    Administration route: Oral
    Indication: Hypertension
    End date: 2010-02-01

Bisoprolol Fumarate
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 2009-12-01

Fenofibrate
    Administration route: Oral
    Indication: Hypertriglyceridaemia

Aspirin
    Administration route: Oral
    Indication: Congestive Cardiomyopathy
    Start date: 1999-12-01

Kayexalate
    Administration route: Oral
    Indication: Hyperkalaemia
    Start date: 2010-05-01

Other drugs received by patient: Victoza; Metformin HCL



Possible Kayexalate side effects in 34 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-01

Patient: 34 year old female

Reactions: Maternal Exposure During Pregnancy, Foetal Death, Premature Delivery

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tixocortol Pivalate
    Dosage: 2 gtt, 2x/day
    Start date: 2008-10-31
    End date: 2008-11-07

Imuran
    Dosage: 0.5 df, 1x/day
    Start date: 2008-09-06
    End date: 2008-09-16

Neoral
    Dosage: 100 mg, 2x/day
    End date: 2008-10-21

Kayexalate
    Dosage: unk
    Start date: 2008-08-05
    End date: 2008-11-15

Acetylcysteine
    Dosage: unk
    Start date: 2008-11-07
    End date: 2008-11-10

Lasix
    Dosage: 500 mg, 2x/day
    Start date: 2008-06-13
    End date: 2008-12-15

Folic Acid
    Dosage: 5 mg, 2x/day
    Start date: 2008-10-08
    End date: 2008-12-17

Mucomyst
    Dosage: 200 mg, 2x/day
    Start date: 2008-11-07
    End date: 2008-11-10

Cefpodoxime Proxetil
    Dosage: 100 mg, 2x/day
    Start date: 2008-11-07
    End date: 2008-11-17

Rubozinc
    Dosage: 15 mg, 1x/day
    Start date: 2008-08-29
    End date: 2008-09-16

Nexium
    Dosage: 40 mg, 1x/day
    Start date: 2008-06-13
    End date: 2008-08-21

Atarax
    Dosage: 25 mg, 1x/day
    Start date: 2008-08-18
    End date: 2008-12-17

Kayexalate
    Dosage: unk
    Start date: 2008-06-13
    End date: 2008-08-04

Erythromycin
    Dosage: unk
    Start date: 2008-08-29
    End date: 2008-09-16

UN-Alfa
    Dosage: 0.5 ug, 1x/day
    Start date: 2008-07-04
    End date: 2008-10-17

Aranesp
    Dosage: 60 ug, weekly
    Start date: 2008-08-27
    End date: 2008-09-28

Amlodipine Besylate
    Dosage: 5 mg, 1x/day
    Start date: 2008-06-20
    End date: 2008-09-16

Neoral
    Dosage: 25 mg, 2x/day
    Start date: 2008-11-06
    End date: 2008-12-17

Renagel
    Dosage: 800 mg, 3x/day
    Start date: 2008-08-28
    End date: 2008-12-15

Isotretinoin
    Dosage: unk
    Start date: 2008-08-29
    End date: 2008-09-16

Nexium
    Dosage: 20 mg, 1x/day
    Start date: 2008-08-22
    End date: 2008-12-17

Amlodipine Besylate
    Dosage: 10 mg, 1x/day
    Start date: 2008-09-17
    End date: 2008-12-15

Venofer
    Dosage: 100 ug, tree time x week
    Start date: 2008-10-17
    End date: 2008-12-14

Venofer
    Dosage: 100 ug, twice x week
    Start date: 2008-12-15
    End date: 2008-12-17

Imuran
    Dosage: 1.5 df, 2x/day
    Start date: 2008-06-13
    End date: 2008-08-21

Neoral
    Dosage: 50 mg, 2x/day
    Start date: 2008-10-22
    End date: 2008-11-05

Aranesp
    Dosage: 80 ug, unk
    Start date: 2008-09-29
    End date: 2008-12-17

Imuran
    Dosage: 1 df, 2x/day
    Start date: 2008-08-22
    End date: 2008-09-05

Venofer
    Dosage: 100 ug, twice x week
    Start date: 2008-06-13
    End date: 2008-10-16



Possible Kayexalate side effects in 34 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-29

Patient: 34 year old female

Reactions: Stillbirth, Foetal Exposure During Pregnancy, Renal Graft Loss

Drug(s) suspected as cause:
Venofer
    Dosage: 100 mg, qw2
    Start date: 2008-12-15
    End date: 2008-12-17

Neoral
    Dosage: 50 mg, bid
    Administration route: Oral
    Start date: 2008-10-22
    End date: 2008-11-05

Kayexalate
    Dosage: 2 df, qd
    Administration route: Oral
    Start date: 2008-08-05
    End date: 2008-11-15

Mucomyst
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2008-11-07
    End date: 2008-11-10

Acetylcysteine
    Dosage: 2 df, qd
    Start date: 2008-11-07
    End date: 2008-11-10

Cefpodoxime Proxetil
    Dosage: 100 mg, bid
    Administration route: Oral
    Start date: 2008-11-07
    End date: 2008-11-17

Erythromycin
    Dosage: 1 df, bid
    Administration route: Topical
    Start date: 2008-08-29
    End date: 2008-09-16

Lasix
    Dosage: 500 mg, bid
    Administration route: Oral
    Start date: 2008-06-13
    End date: 2008-12-15

Esomeprazole Sodium
    Dosage: 40 mg, qd
    Administration route: Oral
    Start date: 2008-06-13
    End date: 2008-08-21

Imuran
    Dosage: 50 mg, bid
    Administration route: Oral
    Start date: 2008-08-22
    End date: 2008-09-05

Atarax
    Dosage: 25 mg, qd
    Administration route: Oral
    Start date: 2008-08-18
    End date: 2008-12-17

Rubozinc
    Dosage: 15 mg, qd
    Administration route: Oral
    Start date: 2008-08-29
    End date: 2008-09-16

Neoral
    Dosage: 100 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2008-08-01
    End date: 2008-10-21

Neoral
    Dosage: 25 mg, bid
    Administration route: Oral
    Start date: 2008-11-06
    End date: 2008-12-17

Imuran
    Dosage: 75 mg, bid
    Administration route: Oral
    Start date: 2008-06-13
    End date: 2008-08-21

Kayexalate
    Dosage: 1 df, qd
    Administration route: Oral
    Start date: 2008-06-13
    End date: 2008-08-04

Venofer
    Dosage: 100 mg, qw3
    Start date: 2008-10-17
    End date: 2008-12-14

Renagel
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2008-08-28
    End date: 2008-12-15

Pivalone
    Dosage: 2 drops bid
    Start date: 2008-10-31
    End date: 2008-11-07

Folic Acid
    Dosage: 5 mg, bid
    Administration route: Oral
    Start date: 2008-10-08
    End date: 2008-12-17

Esomeprazole Sodium
    Dosage: 20 mg, qd
    Administration route: Oral
    Start date: 2008-08-22
    End date: 2008-12-17

Aranesp
    Dosage: 80 ug, qw2
    Start date: 2008-09-29
    End date: 2008-12-17

Imuran
    Dosage: 25 mg, qd
    Administration route: Oral
    Start date: 2008-09-06
    End date: 2008-09-16

Amlodipine Besylate
    Dosage: 5 mg, qd
    Administration route: Oral
    Start date: 2008-06-20
    End date: 2008-09-16

Isotretinoin
    Dosage: 1 df, bid
    Administration route: Topical
    Start date: 2008-08-29
    End date: 2008-09-16

Amlodipine Besylate
    Dosage: 10 mg, qd
    Administration route: Oral
    Start date: 2008-09-17
    End date: 2008-12-15

UN-Alfa
    Dosage: 0.5 ug, qd
    Administration route: Oral
    Start date: 2008-07-04
    End date: 2008-10-17

Aranesp
    Dosage: 60 ug, qw
    Start date: 2008-07-27
    End date: 2008-09-28

Venofer
    Dosage: 100 mg, qw2
    Start date: 2008-06-13
    End date: 2008-10-16



Possible Kayexalate side effects in 56 year old male

Reported by a pharmacist from Canada on 2012-02-16

Patient: 56 year old male

Reactions: Dyspnoea, Hyperkalaemia, Pain

Drug(s) suspected as cause:
Kayexalate

Other drugs received by patient: Furosemide; Atorvastatin; Amlodipine; Hydralazine HCL; Atenolol; Pantoprazole; Gliclazide



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-14

Patient: 53 year old male

Reactions: Leukocytoclastic Vasculitis, Renal Impairment, Sepsis, Anaemia, Dizziness, Hydrocephalus, Thrombocytopenia, Nephropathy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone TAB
    Administration route: Oral
    Start date: 2011-05-01

Keppra
    Administration route: Oral

Ramipril
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-14

Repaglinide
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2011-06-03
    End date: 2011-06-26

Eupressyl
    Administration route: Oral
    Start date: 2011-05-29

Prednisolone
    Administration route: Oral
    Start date: 2011-06-05
    End date: 2011-06-26

Calcium Carbonate
    Administration route: Oral

Amlodipine Besylate
    Administration route: Oral

Prednisolone
    Administration route: Oral
    Start date: 2011-06-30

Kayexalate
    Administration route: Oral
    Start date: 2011-06-03
    End date: 2011-06-26

Citalopram
    Dosage: 20
    Administration route: Oral

Renagel
    Administration route: Oral

Atorvastatin
    Administration route: Oral
    Start date: 2011-05-30
    End date: 2011-06-24

Aranesp
    Dosage: 50mug

Other drugs received by patient: Solu-Medrol; Solu-Medrol



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-06

Patient: 53 year old male

Reactions: Tubulointerstitial Nephritis, Renal Impairment, Sepsis, Dizziness, Hydrocephalus, Nephropathy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Amlodipine Besylate
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Citalopram Base
    Dosage: unk
    Administration route: Oral

Kayexalate
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-03
    End date: 2011-06-26

Prednisolone
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-27

Prednisolone
    Dosage: unk
    Start date: 2011-06-30

Atorvastatin
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-30
    End date: 2011-06-24

Eupressyl
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29

Keppra
    Dosage: unk
    Administration route: Oral

Repaglinide
    Dosage: unk
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2011-06-03
    End date: 2011-06-26

Ramipril
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-14

Other drugs received by patient: Fucidine CAP; Methylprednisolone; Solu-Medrol; Locoid



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-06

Patient: 53 year old male

Reactions: Leukocytoclastic Vasculitis, Sepsis, Dizziness, Hydrocephalus, Nephropathy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Amlodipine Besylate
    Administration route: Oral

Ramipril
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-14

Prednisolone
    Administration route: Oral
    Start date: 2011-06-30

Atorvastatin
    Administration route: Oral
    Start date: 2011-05-30
    End date: 2011-06-24

Keppra
    Administration route: Oral

Kayexalate
    Administration route: Oral
    Start date: 2011-06-03
    End date: 2011-06-26

Citalopram Hydrobromide
    Administration route: Oral

Repaglinide
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2011-06-03
    End date: 2011-06-26

Eupressyl
    Administration route: Oral
    Start date: 2011-05-29

Prednisolone
    Administration route: Oral
    Start date: 2011-06-05
    End date: 2011-06-26

Other drugs received by patient: Solu-Medrol; Solu-Medrol



Possible Kayexalate side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-03

Patient:

Reactions: Renal Impairment, Anaemia, Sepsis, Hydrocephalus, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Eupressyl
    Dosage: 30 mg, tid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29

Calciparine
    Dosage: 0.2 ml, sc
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-08
    End date: 2011-08-08

Aranesp
    Dosage: 50 mcg, every 15 days
    Indication: Product Used FOR Unknown Indication

Kayexalate
    Dosage: 15 g, 3x/w
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-03

Citalopram Hydrobromide
    Dosage: 20 mg/kg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Calcium Carbonate
    Dosage: 1 unk, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Renagel
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Hyperphosphataemia

Prednisone TAB
    Dosage: 30 mg/kg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-01

Depakene
    Dosage: 500 mg/kg, bid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-16



Possible Kayexalate side effects in 53 year old male

Reported by a physician from France on 2012-02-03

Patient: 53 year old male

Reactions: Anaemia, Condition Aggravated, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aranesp
    Dosage: 50 mug, q2wk
    Indication: Product Used FOR Unknown Indication

Prednisone TAB
    Dosage: 30 mg/kg, qd
    Administration route: Oral
    Start date: 2011-05-01

Keppra

Eupressyl
    Dosage: 90 mg, qd
    Administration route: Oral
    Start date: 2011-05-29

Kayexalate
    Dosage: 15 g, 3 times/wk
    Administration route: Oral
    Start date: 2011-06-03

Citalopram Hydrobromide
    Dosage: 20 unk, unk
    Administration route: Oral

Calcium Carbonate
    Dosage: unk
    Administration route: Oral

Renagel
    Dosage: unk unk, qd
    Administration route: Oral



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-02

Patient: 53 year old male

Reactions: Tubulointerstitial Nephritis, Renal Impairment, Dizziness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Atorvastatin
    Dosage: unk
    Administration route: Oral
    Start date: 2011-05-30
    End date: 2011-06-14

Repaglinide
    Dosage: unk
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2011-06-03
    End date: 2011-06-26

Eupressyl
    Dosage: unk
    Administration route: Oral
    Start date: 2011-05-29

Keppra
    Dosage: unk
    Administration route: Oral

Amlodipine Besylate
    Dosage: unk
    Administration route: Oral

Prednisolone
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-27

Kayexalate
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-03
    End date: 2011-06-26

Citalopram
    Dosage: unk
    Administration route: Oral

Ramipril
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-14

Other drugs received by patient: Fucidine CAP; Locoid; Solu-Medrol



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-01

Patient: 53 year old male

Reactions: Tubulointerstitial Nephritis, Renal Impairment, Sepsis, Dizziness, Hydrocephalus, Nephropathy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kayexalate
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-03
    End date: 2011-06-26

Prednisolone
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-27

Prednisolone
    Dosage: unk
    Start date: 2011-06-30

Repaglinide
    Dosage: unk
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2011-06-03
    End date: 2011-06-26

Atorvastatin
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-30
    End date: 2011-06-24

Eupressyl
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29

Amlodipine Besylate
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ramipril
    Dosage: unk
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-14

Keppra
    Dosage: unk
    Administration route: Oral

Citalopram Base
    Dosage: unk
    Administration route: Oral

Other drugs received by patient: Solu-Medrol; Fucidine CAP; Methylprednisolone; Locoid



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-01

Patient: 53 year old male

Reactions: Renal Failure, Anaemia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Calciparine
    Dosage: parenteral injection
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-08
    End date: 2011-08-08

Kayexalate
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-03

Depakene
    Dosage: extended release
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-07-16

Renagel
    Dosage: daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Prednisone TAB
    Dosage: daily
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-01

Aranesp
    Indication: Product Used FOR Unknown Indication

Citalopram Hydrobromide
    Dosage: daily
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Eupressyl
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-05-29

Calcium Carbonate
    Dosage: daily
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Keppra



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-31

Patient: 53 year old male

Reactions: Tubulointerstitial Nephritis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Citalopram
    Administration route: Oral

Kayexalate
    Administration route: Oral
    Start date: 2011-06-03
    End date: 2011-06-26

Prednisolone
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-27

Keppra
    Administration route: Oral

Eupressyl
    Administration route: Oral
    Start date: 2011-05-29

Ramipril
    Administration route: Oral
    Start date: 2011-06-04
    End date: 2011-06-14

Repaglinide
    Administration route: Oral
    Start date: 2011-06-03
    End date: 2011-06-26

Atorvastatin
    Administration route: Oral
    Start date: 2011-05-30
    End date: 2011-06-14

Amlodipine Besylate
    Administration route: Oral



Possible Kayexalate side effects in 56 year old male

Reported by a pharmacist from Canada on 2012-01-27

Patient: 56 year old male

Reactions: Dyspnoea, Hyperkalaemia, Pain

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kayexalate

Other drugs received by patient: Pantoprazole; Furosemide; Hydralazine HCL; Atorvastatin; Gliclazide; Amlodipine; Atenolol



Possible Kayexalate side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-27

Patient: 53 year old male

Reactions: Renal Failure, Anaemia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kayexalate
    Administration route: Oral
    Start date: 2011-06-03

Calcium Carbonate

Aranesp

Calciparine
    Start date: 2011-07-08
    End date: 2011-08-08

Eupressyl
    Administration route: Oral
    Start date: 2011-05-29

Prednisone TAB
    Start date: 2011-05-01

Renagel
    Administration route: Oral

Citalopram Hydrobromide
    Administration route: Oral

Depakene
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-07-16

Other drugs received by patient: Keppra



Possible Kayexalate side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-25

Patient: 65 year old female

Reactions: Drug Ineffective, Blood Thyroid Stimulating Hormone Increased, Drug Interaction, General Physical Health Deterioration, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Calcium Carbonate
    Dosage: 4 df (2 df, in the morning and in the evening)
    Indication: Product Used FOR Unknown Indication

Fucidine CAP
    Dosage: 4 df (2 df, in the morning and in the evening)
    Indication: Osteitis
    Start date: 2011-05-01
    End date: 2011-08-01

Cordarone
    Indication: Cardiac Disorder
    Start date: 2011-05-01

Levothyroxine Sodium
    Indication: Thyroidectomy
    Start date: 2010-01-01

Levofloxacin
    Dosage: 0.5 df (0.5 df, in the morning)
    Indication: Product Used FOR Unknown Indication
    End date: 2011-08-01

Fosrenol
    Dosage: 3 gm (1 gm, in the morning, midday, in the evening)
    Indication: Product Used FOR Unknown Indication

Kayexalate
    Dosage: (1 df, 4 in 1 wk) (punctually)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-08-01

Other drugs received by patient: Lexomil (Bromazepam) (Bromazepam); Cardensiel (Bisoprolol Fumarate) (Bisoprolol Hemifumarate); Stablon (Tianeptine) (Tianeptine); Inipomp (Pantoprazole) (40 MG) (Pantoprazole); Furosemide; Clopidogrel; Tahor (Atorvastatin Calcium) (10 MG, Tablet) (Atorvastatin); Ixprim (Ultracet) (Tramadol, Paracetamol); Insulin; Procoralan (Ivabradine Hydrochloride) (5 MG) (Ivabradine)

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012